These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH, Schlegel U, Heneka MT. Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936 [Abstract] [Full Text] [Related]
25. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S. Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600 [Abstract] [Full Text] [Related]
26. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O. Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626 [Abstract] [Full Text] [Related]
29. Vascular effects of PPARgamma activators - from bench to bedside. Marx N, Walcher D. Prog Lipid Res; 2007 Nov; 46(6):283-96. PubMed ID: 17637478 [Abstract] [Full Text] [Related]
30. Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells. Wang PS, Chou FS, Porchia L, Saji M, Pinzone JJ. Mol Carcinog; 2008 Dec; 47(12):905-15. PubMed ID: 18314876 [Abstract] [Full Text] [Related]
31. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Duan SZ, Usher MG, Mortensen RM. Circ Res; 2008 Feb 15; 102(3):283-94. PubMed ID: 18276926 [Abstract] [Full Text] [Related]
32. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. Ringseis R, Schulz N, Saal D, Eder K. J Nutr Biochem; 2008 Sep 15; 19(9):594-603. PubMed ID: 18155510 [Abstract] [Full Text] [Related]
33. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. Wang K, Zhou Z, Zhang M, Fan L, Forudi F, Zhou X, Qu W, Lincoff AM, Schmidt AM, Topol EJ, Penn MS. J Pharmacol Exp Ther; 2006 Apr 15; 317(1):37-43. PubMed ID: 16368901 [Abstract] [Full Text] [Related]
34. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture. Fröhlich E, Machicao F, Wahl R. Endocr Relat Cancer; 2005 Jun 15; 12(2):291-303. PubMed ID: 15947104 [Abstract] [Full Text] [Related]
38. Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes. Chung SS, Choi HH, Cho YM, Lee HK, Park KS. Biochem Biophys Res Commun; 2006 Sep 15; 348(1):253-8. PubMed ID: 16876120 [Abstract] [Full Text] [Related]